Journal article
Clinical Outcomes Associated With Escherichia coli Infections in Adults With Cystic Fibrosis: A Cohort Study
Abstract
BACKGROUND: Analysis of "emerging" pathogens in cystic fibrosis (CF) lung disease has focused on unique pathogens that are rare in other human diseases or are drug resistant. Escherichia coli is recovered in the sputum of up to 25% of patients with CF, yet little is known about the epidemiology or clinical impact of infection.
METHODS: We studied patients attending a Canadian adult CF clinic who had positive sputum cultures for E coli from 1978 …
Authors
Edwards BD; Somayaji R; Greysson-Wong J; Izydorczyk C; Waddell B; Storey DG; Rabin HR; Surette MG; Parkins MD
Journal
Open Forum Infectious Diseases, Vol. 7, No. 1,
Publisher
Oxford University Press (OUP)
Publication Date
January 1, 2020
DOI
10.1093/ofid/ofz476
ISSN
2328-8957